From:
(SANTE)
Sent:
Wednesday 31 March 2021 15:09
To:
SANTE)
Subject:
BTO report: presentation of RRF (health system focus) to of AmCham EU’s healthcare
committee
Attachments:
2021-03-30 AmCham.pptx; 2021-03-30 AmCham.pptx
Dear
Yesterday I joined the AmCham EU’s healthcare committee (30 March 1.30)PM – 2.30PM) to present the Recovery and
Resilience Facility.
The presentation was delivered following AmCham’s request to the Commission.
Next to
(AmCham) the below industry representatives attended.
I presented the attached PPT
From the floor I received the following questions:
The role of the RRF as regards long‐term care and the digital transformation
o
I reiterated general eligibility criteria
o I explained eHealth was explicitly referred to in the Commission’s RRP guidance
o I referred to various country reports across European Semesters that also touched upon coordination
challenges between healthcare and long‐term care
The need for certain high‐cost medicines to be considered as “investments” (for national accounting purposes)
o I referred to parallel debates:
Pharmaceutical strategy and novel payment models
Eurostat and accounting rules
The need to ensure long‐term reform momentum, also in the macro‐economic aftermath of COVID‐19
o I explained that one of the assessment criteria as explained in RRP guidance deals with the sustainability
of investments
o Overall, prior to COVID‐19 health systems were showing showing promising signs of resiliently coping
with demographic ageing( e.g. healthcare expenditures as a share of GDP stabilized)
(there was also a request to comment on the inception impact assessment/roadmap published yesterday on the review
of the EU pharmaceutical acquis, which I declined)
1
European Commission
Directorate-General for Health and Food Safety
Unit B1 Performance of national health systems
B-1049 Brussels/Belgium
+
@ec.europa.eu
2